Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-03-16FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s supplemental application for Montelukast Sodium.
-
CLINICAL_TRIALS trial_result · 2015-03-13Clinical Trial Update: Controlled Trial of Chinese Herbal Medicine to Treat Allergic Rhinitis [Phase 1, Phase 2]
A controlled trial of a Chinese herbal medicine regimen for allergic rhinitis has completed Phase 1 and Phase 2.
-
FDA approval · 2015-03-12FDA Approved: MONTELUKAST SODIUM — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved Montelukast Sodium from Macleods Pharmaceuticals Limited under an Original Application (ANDA 203582).
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: Pilot Study of Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis [Phase 1]
Phase 1 pilot study of intralymphatic immunotherapy (ILIT) for allergic rhinitis triggered by house dust mite, cat, and dog allergens has co…
-
FDA approval · 2015-02-25FDA Approved: FEXOFENADINE HYDROCHLORIDE — Supplemental Application (AMERISOURCE BERGEN)
FDA approved a supplemental application for fexofenadine hydrochloride submitted by Amerisource Bergen, updating the regulatory status of th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-02-20FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) submitted by Viatris Specialty…
-
FDA approval · 2015-02-18FDA Approved: MOMETASONE FUROATE — Supplemental Application (Encube Ethicals, Inc.)
FDA approved a supplemental application for mometasone furoate from Encube Ethicals, Inc., granting approval of a supplemental ANDA for this…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis [NA]
The trial update reports changes in specific immunoglobulin levels and blood basophil activity during subcutaneous immunotherapy for allergi…
-
FDA approval · 2015-02-11FDA Approved: DESLORATADINE — Supplemental Application (Bionpharma Inc.)
The FDA approved a supplemental application for desloratadine filed by Bionpharma Inc.
-
FDA approval · 2015-02-11FDA Approved: DESLORATADINE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for desloratadine from Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2015-02-05Clinical Trial Update: Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy [Phase 3]
Phase 3 study results evaluate the efficacy and safety of short ragweed pollen sublingual immunotherapy for ragweed allergy. Results have be…
-
FDA approval · 2015-02-03FDA Approved: QNASL — Supplemental Application (Teva Respiratory, LLC)
The FDA approved a supplemental application for QNASL (beclomethasone dipropionate) submitted by Teva Respiratory, LLC.
-
FDA approval · 2015-01-29FDA Approved: FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE — Original Application (AmeriSource Bergen)
FDA approved the original ANDA for a combination product of fexofenadine hydrochloride and pseudoephedrine hydrochloride to relieve allergy …
-
FDA approval · 2015-01-24FDA Approved: HYDROXYZINE PAMOATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva’s supplemental application for hydroxyzine pamoate, confirming its status as an approved generic drug. The action rela…
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: MSM Product on Attenuating Nasal Provocation With a Standardized Allergenic Challenge [Phase 2]
This update reports the completion of a Phase 2 trial assessing an MSM product for attenuating nasal provocation with a standardized allerge…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Persistent Allergic Rhinitis Treatment [Phase 3]
Phase 3 clinical trial comparing desloratadine with prednisolone oral solution versus dexchlorpheniramine with betamethasone for persistent …
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies [Phase 3]
Phase 3 efficacy study evaluates a ragweed sublingual immunotherapy product for allergic rhinitis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Clinical Effects of Temperature Controlled Laminar Airflow (TLA) [Phase 2]
Phase 2 trial evaluating the clinical effects of Temperature Controlled Laminar Airflow (TLA) has completed, studying individuals with asthm…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: An Open Trial to Assess the Tolerability of AVANZ Mite Mix Immunotherapy [Phase 2, Phase 3]
An open Phase 2/Phase 3 trial evaluating the tolerability of AVANZ Mite Mix Immunotherapy for allergic rhinitis due to dust mite has complet…
-
CLINICAL_TRIALS trial_result · 2015-01-05Clinical Trial Update: To Determine the Minimum Amount of Artemisia Vulgaris Allergen Extract Producing a Positive Skin Reaction. [Phase 2]
A Phase 2 trial completed to determine the minimum dose of Artemisia vulgaris allergen extract that produces a positive skin reaction in ind…
-
FDA approval · 2014-12-30FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for cetirizine hydrochloride by Rising Pharma Holdings, Inc., expanding regulatory approval for …
-
FDA approval · 2014-12-02FDA Approved: ALLEGRA HIVES 24HR — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Allegra Hives 24HR (fexofenadine hydrochloride) from Chattem, Inc., indicating a regulatory …
-
FDA approval · 2014-11-26FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
FDA approval · 2014-11-18FDA Approved: FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original application for a fixed-dose combination of fexofenadine HCl and pseudoephedrine HCl from Dr. Reddy's Laboratories…
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484) [Phase 3]
Phase 3 trial evaluating the safety of a Montelukast and Loratadine combination in Mexican participants with allergic rhinitis; the study ha…